Literature DB >> 30499630

How I investigate Eosinophilia.

Rebecca L Larsen1, Natasha M Savage1.   

Abstract

Eosinophilia is typically secondary, that is, reactive, in nature and is associated with a wide variety of neoplastic and non-neoplastic disorders. Clonal eosinophilia is also seen in a wide variety of hematopoietic neoplasms, and sub-classification can be diagnostically challenging. A proper evaluation of persistent eosinophilia involves correlation of clinical history, laboratory data, cellular morphology, and ancillary testing. Knowledge of appropriate ancillary testing is necessary for a timely diagnosis. We present a review of the literature regarding eosinophilia, including the 2016 World Health Organization (WHO) update of WHO-defined eosinophilic disorders. We also present a review of eosinophilia in a case-based format including guidelines for evaluation of both routine and challenging cases. The purpose of this guideline is not to provide an in-depth discussion of each diagnosis, but rather a practical method that all pathologists can utilize to investigate eosinophilia.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  blood; bone marrow; eosinophils; leukemia; morphology; myeloid

Mesh:

Year:  2018        PMID: 30499630     DOI: 10.1111/ijlh.12955

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  7 in total

1.  Pulmonary Adenocarcinoma Presenting as Acute Heart Failure and Hypereosinophilia.

Authors:  Diana Ferrão; Clara Silva; Jorge S Almeida
Journal:  Cureus       Date:  2022-01-20

2.  Myeloproliferative Syndrome With Eosinophilia Associated With Translocation t(8; 13) and T-cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature.

Authors:  Lizeth Yamile Urrea Pineda; Oliver Perilla; Vanessa Santiago-Pacheco; Simon Trujillo Montoya
Journal:  Cureus       Date:  2022-03-01

3.  Marked hypereosinophilia secondary to endometrioid ovarian cancer presenting with asthma symptoms, a case report.

Authors:  Hasan Ahmad Hasan Albitar; Ashley M Egan; Hassan Alkhateeb; Yahya Almodallal; Vivek N Iyer
Journal:  Respir Med Case Rep       Date:  2020-07-28

4.  Predictive value and clinical significance of increased SSAT-1 activity in healthy adults.

Authors:  Paramjit S Tappia; Andrew W Maksymiuk; Daniel S Sitar; Parveen S Akhtar; Nazrina Khatun; Rahnuma Parveen; Rashiduzzaman Ahmed; Rashid B Ahmed; Brian Cheng; Gina Huang; Horacio Bach; Brett Hiebert; Bram Ramjiawan
Journal:  Future Sci OA       Date:  2019-07-01

5.  Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2.

Authors:  Sascha Troschke-Meurer; Nikolai Siebert; Madlen Marx; Maxi Zumpe; Karoline Ehlert; Oliver Mutschlechner; Hans Loibner; Ruth Ladenstein; Holger N Lode
Journal:  Oncoimmunology       Date:  2019-09-08       Impact factor: 8.110

6.  A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.

Authors:  Magda Zanelli; Maxwell Smith; Maurizio Zizzo; Angelo Carloni; Riccardo Valli; Loredana De Marco; Moira Foroni; Andrea Palicelli; Giovanni Martino; Stefano Ascani
Journal:  BMC Pulm Med       Date:  2019-11-19       Impact factor: 3.317

7.  Portal vein thrombosis and food protein-induced allergic proctocolitis in a premature newborn with hypereosinophilia: a case report.

Authors:  Cheong-Jun Moon; Tae Hee Kwon; Hyun-Seung Lee
Journal:  BMC Pediatr       Date:  2021-01-23       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.